← All companies

ACIU

AC Immune SA

ACIU Nasdaq Pharmaceutical Preparations EDGAR ↗

$2.27

+0.05 +2.25%

Key statistics

from XBRL data in SEC filings

Market cap

$231M

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

—

Total assets

—

Gross margin

—

52-week range

$2.03 – $4.00

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K FORM 6-K Jun 30, 2026 6-K FORM 6-K Jun 11, 2026 6-K FORM 6-K Jun 11, 2026 6-K FORM 6-K May 15, 2026 6-K FORM 6-K May 12, 2026 6-K FORM 6-K Apr 30, 2026 6-K FORM 6-K Apr 30, 2026 6-K FORM 6-K Apr 7, 2026 6-K Mar 13, 2026 20-F Mar 13, 2026 6-K FORM 6-K Feb 24, 2026 6-K FORM 6-K Feb 17, 2026 6-K FORM 6-K Dec 11, 2025 6-K Nov 4, 2025 6-K FORM 6-K Sep 4, 2025 6-K Aug 5, 2025 6-K FORM 6-K Jun 20, 2025 6-K FORM 6-K Jun 11, 2025 6-K FORM 6-K May 19, 2025 6-K Apr 30, 2025 6-K FORM 6-K Mar 13, 2025 20-F Mar 13, 2025 6-K FORM 6-K Dec 18, 2024 6-K FORM 6-K Dec 10, 2024 6-K FORM 6-K Nov 14, 2024 6-K Nov 5, 2024 6-K FORM 6-K Sep 19, 2024 6-K FORM 6K Sep 17, 2024 6-K FORM 6-K Aug 28, 2024 6-K FORM 6-K Aug 6, 2024 6-K Aug 6, 2024 6-K FORM 6-K Jul 31, 2024 6-K FORM 6-K Jul 25, 2024 6-K FORM 6-K Jun 20, 2024 6-K FORM 6-K May 21, 2024 6-K May 13, 2024 6-K FORM 6-K May 13, 2024 6-K FORM 6-K Mar 14, 2024 20-F Mar 14, 2024 6-K FORM 6-K Jan 22, 2024